On October 31, 2022, AIM ImmunoTech Inc announced that the Delaware Court of Chancery has denied Jonathan Jorgl's motion for a mandatory preliminary injunction that sought to require the Company board to accept his director nominations and include his nominees on a universal proxy card for the upcoming annual meeting of shareholders. In addition, the Company urged the shareholders to vote for its board nominees THOMAS K EQUELS, WILLIAM M MITCHELL AND STEWART L APPELROUTH, at the annual meeting of shareholders scheduled to be held on November 3, 2022.